Business
New Corporate Video and Investor Webinar
New Corporate Video and Investor Webinar.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n \n \n RNS Number : 0575S\n Hemogenyx Pharmaceuticals PLC\n 06 July 2020\n \n \n \n \n 6 July 2020\n \n \n Hemogenyx Pharmaceuticals plc\n \n \n (\"Hemogenyx Pharmaceuticals\" or the \"Company\")\n \n \n New Corporate Video and Investor Webinar\n \n \n Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a new corporate video is available to view on the Company's website and can be accessed by following the link: \n \n \n https://youtu.be/LP95GWupyNA\n \n \n In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company's current activities. If you would like to register for the webinar, please follow this link:\n \n \n \n \n \n \n \n https://us02web.zoom.us/meeting/register/tZIocuyrqj4pH9HRgZuobXLJdSDkRXUDFRDU\n \n \n \n \n \n \n \n After registering, you will receive a confirmation email containing information about joining the meeting.\n \n \n \n \n \n Please submit your questions in advance and not later than 17 July 2020 by emailing \n \n \n [email protected]\n \n \n .\n \n \n \n \n \n \n \n \n Enquiries:\n \n \n \n \n \n \n \n \n Hemogenyx Pharmaceuticals plc\n \n \n \n \n www.hemogenyx.com\n \n \n \n \n \n \n Dr Vladislav Sandler, Chief Executive Officer & Co-Founder\n \n \n \n \n [email protected]\n \n \n \n \n \n \n Peter Redmond, Director\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n SP Angel Corporate Finance LLP\n \n \n \n \n Tel: +44 (0)20 3470 0470\n \n \n \n \n \n \n Matthew Johnson, Vadim Alexandre, Soltan Tagiev\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Peterhouse Capital Limited\n \n \n \n \n Tel: +44 (0)20 7469 0930\n \n \n \n \n \n \n Lucy Williams, Duncan Vasey, Charles Goodfellow\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n US Media enquiries\n \n \n \n \n Tel: +1 ...